Back to News
Market Impact: 0.35

Shares of P&G Struggled in 2025. What Will It Do in 2026?

PGWMTTGTCOSTNFLXNVDANDAQ
Consumer Demand & RetailTax & TariffsTrade Policy & Supply ChainEmerging MarketsCompany FundamentalsCapital Returns (Dividends / Buybacks)M&A & RestructuringInvestor Sentiment & Positioning
Shares of P&G Struggled in 2025. What Will It Do in 2026?

Procter & Gamble shares are down more than 13% year-to-date as of Dec. 15 after the company grew 2% in fiscal 2025 and reiterated exposure to macro risks including inflation, unemployment and tariff pressures. Management is pursuing geographic expansion into emerging markets and potential brand acquisitions to offset U.S. saturation and rising competition from private labels, while earlier guidance included a roughly $1 billion tariff-related hit and the firm continues to pay a $1.06 quarterly dividend.

Analysis

Market structure: Premium CPG (PG) is the primary loser as consumer downtrading accelerates; winners are retailer private-label champions (WMT, TGT, COST) that gain pricing leverage and volume. Expect 100–300 bps of category share migration to private labels in an unemployment-driven soft patch (>6% U.S. unemployment) and a 1–2% margin contraction at PG if tariffs persist at current levels (the company flagged ~$1B earlier). Cross-asset: rising CPG risk pushes defensive bid into high-grade bonds (spread compression 10–30 bps) and increases PG implied-volatility short-term; commodity inputs (palm oil, pulp) and USD strength will amplify margin swings for global producers expanding into EMs. Risk assessment: Tail risks include a renewed tariff surge (up to 25% on key inputs) that recreates a $1B+ annual EBIT hit, or a deep consumer recession reducing P&G FY26 organic sales by >4–6%. Immediate risks (days–weeks) are tariff/CPI/unemployment prints and retailers’ holiday results; short-term (3–6 months) hinge on Q3/FY26 guidance and promotional response; long-term (12–36 months) depends on successful EM expansion and brand M&A execution. Hidden dependencies: private-label adoption correlates non-linearly with sustained wage pressure and retailer economics; a P&G M&A to refocus into beauty could re-rate multiples quickly. Trade implications: Direct plays — overweight COST and WMT (total 4–6% portfolio exposure) for 6–12 months; initiate a tactical short or buy-put spread on PG (6-month put spread 15%/5% OTM for defined risk) to monetize downside while avoiding dividend/borrow risk. Pair trade — long TGT vs short PG (equal-dollar, 3–6 month horizon) to capture relative share shift; use 1:1 dollar exposure and monitor same-store sales and promo intensity weekly. Options — favor 3–6 month directional spreads (buy protection/income) over naked positions given elevated event risk; sell covered calls on existing PG holdings to harvest yield if unwilling to sell. Contrarian angles: The market may be overpricing secular collapse — PG’s 13% YTD decline likely embeds a >50% chance of recession; however PG generates >$10B FCF and funds a ~2–3% dividend yield, enabling buybacks or M&A that could re-leverage EPS in 12–24 months. EM expansion and targeted beauty M&A could restore 200–400 bps of margin over 2–3 years if executed; conversely, private-label proliferation could create structural margin pressure meaning PG is a core value-trap unless tariff clarity or EM growth materializes. Watch for management capital allocation shifts (buyback increases or strategic tuck-ins) as the high-probability reversal catalyst.